Anorexia nervosa (AN) is a serious and often fatal illness. Despite decades of research, investigators have failed to adequately advance our understanding of the biological aspects of AN that could inform the development of effective interventions. Genome-wide association studies are revealing the important role of metabolic factors in AN, and studies of the gastrointestinal tract are shedding light on disruptions in enteric microbial communities and anomalies in gut morphology. In this opinion piece, we review the state of the science through the lens of the clinical presentation of illness. We project how the integration of rigorous science in genomics and microbiology, in collaboration with experienced clinicians, has the potential to markedly enhance treatment outcome via precision interventions.
Shifting paradigms in understanding and treating ANAN rests squarely on the psyche-soma border; however, etiological theories and treatments have historically focused on psychological, family, and societal factors. A conceptual shift is underway. The latest genome-wide association study (GWAS; see Glossary) for AN [1] suggested reconceptualizing AN as a 'metabo-psychiatric disorder'. In addition to identifying eight significantly associated genomic loci, a rich panel of genetic correlations underscored the role of psychiatric, anthropometric, and metabolic factors in the etiology of this highly lethal disease.